Effects of estrogen treatment on expression of brain-derived neurotrophic factor and cAMP response element-binding protein expression and phosphorylation in rat amygdaloid and hippocampal structures

Neuroendocrinology

Volumn 81, Issue 5, 2005, Pages 294-310

  Zhou, Jin ^a,b   Zhang, Huaibo ^a,b   Cohen, Rochelle S ^a   Pandey, Subhash C ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Amygdala; Brain derived neurotrophic factor; Calcium calmodulin kinase; cAMP response element binding protein; Gonadal steroids; Hippocampus; Immunocytochemistry; Molecular neuroendocrinology

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM CALMODULIN KINASE IV; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENZYME; ESTROGEN; MESSENGER RNA; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; DENTATE GYRUS; EMOTION; ESTROGEN THERAPY; FEMALE; HIPPOCAMPUS; IMMUNOGOLD LABELING; MALE; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMYGDALA; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL COUNT; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; OVARIECTOMY; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 27344443056     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088448     Document Type: Article

References (102)

1. Woolley CS, Cohen RS: Sex steroids and neuronal growth in adulthood; in Pfaff DW (ed): Hormones, Brains and Behavior. New York, Academic Press, 2002, vol 4, pp 717-777.
2. Scharfman HE, MacLuskey NJ: Similarities between actions of estrogen and BDNF in the hippocampus: Coincidence or clue? Trends Neurosci 2005;28:79-85.
3. Pfaff DW: Hormone-driven mechanisms in the central nervous system facilitate the analysis of mammalian behaviors. J Endocrinol 2005;184:447-453.
4. Cohen RS, Pfaff DW: Ultrastructure of neurons in the ventromedial nucleus of the hypothalamus in ovariectomized rats with or without estrogen treatment. Cell Tissue Res 1981;217:451-470.
5. Chung SK, Pfaff DW, Cohen RS: Estrogen-induced alterations in synaptic morphology in the midbrain central gray. Exp Brain Res 1988;69:522-530.
6. Frankfurt M, Gould E, Woolley CS, McEwen BS: Gonadal steroids modify dendritic spine density in ventromedial hypothalamic neurons: A Golgi study in the adult rat. Neuroendocrinology 1990;51:530-535.
7. Calizo LH, Flanagan-Cato LM: Estrogen selectively regulates spine density within the dendritic arbor of rat ventromedial hypothalamic neurons. J Neurosci 2000;20:1589-1596.
8. Woolley CS, McEwen BS: Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 1992;12:2549-2554.
9. Rasia-Filho AA, Fabian C, Rigoti KM, Achaval M: Influence of sex, estrous cycle and motherhood on dendritic spine density in the rat medial amygdala revealed by the Golgi method. Neuroscience 2004;126:839-847.
10. Murphy DD, Cole NB, Greenberger V, Segal M: Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J Neurosci 1998;18:2550-2559.
11. Rudick CN, Woolley CS: Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci 2001;21:6532-6543.
12. Sohrabji F, Miranda RCG, Toran-Allerand CD: Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci USA 1995;92:11110-11114.
13. Singh M, Meyer EM, Simpkins JW: The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 1995;136:2320-2324.
14. Gibbs RB: Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement. Brain Res 1998;787:259-268.
15. Gibbs RB: Treatment with estrogen and progesterone affects relative levels of brain-derived neurotrophic factor mRNA and protein in different regions of the adult rat brain. Brain Res 1999;844:20-27.
16. Jezierski MK, Sohrabji F: Region- and peptide-specific regulation of the neurotrophins by estrogen. Brain Res Mol Brain Res 2000;85:77-84.
17. Liu Y, Fowler CD, Young LJ, Yan Q, Insel TR, Wang Z: Expression and estrogen regulation of brain-derived neurotrophic factor gene and protein in the forebrain of female prairie voles. J Comp Neurol 2001;433:499-514.
18. Solum DT, Handa RJ: Estrogen regulates the development of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus. J Neurosci 2002;22:2650-2659.
19. 2A agonist treatment on brain-derived neurotrophic factor expression in female rats. Biol Psychiatry 2003;54:59-69.
20. Scharfman HE, Mercurio TC, Goodman JH, Wilson MA, McLusky NJ: Hippocampal excitability increases during the estrus cycle in the rat: A potential role for brain-derived neurotrophic factor. J Neurosci 2003;23:11641-11652.
21. Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME: CREB: A major mediator of neuronal neurotrophin responses. Neuron 1997;19:1031-1047.
22. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1998;20:709-726.
23. Finkbeiner S: Calcium regulation of the brain-derived neurotrophic factor gene. Cell Mol Life Sci 2000;57:394-401.
24. Kobierski LA, Wong AE, Srivastava S, Borsook D, Hyman SE: Cyclic AMP-dependent activation of the proenkephalin gene requires phosphorylation of CREB at serine-133 and a Src-related kinase. J Neurochem 1999;73:129-138.
25. Wilson BE, Mochon E, Boxer LM: Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol 1996;16:5546-5556.
26. Panickar KS, Guan G, King MA, Simpkins JW: 17β-Estradiol attenuates CREB decline in the rat hippocampus following seizure. J Neurobiol 1997;3:961-967.
27. Gu G, Rojo AA, Zee MC, Yu J, Simerly RB: Hormonal regulation of CREB phosphorylation in the anteroventral periventricular nucleus. J Neurosci 1996;16:3035-3044.
28. Zhou Y, Watters JJ, Dorsa DM: Estrogen rapidly induces the phosphorylation of the cAMP response element-binding protein in rat brain. Endocrinology 1996;137:2163-2166.
29. Beyer C, Karolczak M: Estrogenic stimulation of neurite growth in midbrain dopaminergic neurons depends on cAMP/protein kinase A signalling. J Neurosci Res 2000;59:107-116.
30. Abrahám IM, Han SK, Todman MG, Korach KS, Herbison AE: Estrogen receptor-β mediates rapid estrogen actions on gonadotropin-releasing hormone neurons in vivo. J Neurosci 2003;23:5771-5777.
31. Abrahám IM, Todman MG, Korach KS, Herbison AE: Critical in vivo roles for classical estrogen receptors in rapid estrogen actions on intracellular signaling in mouse brain. Endocrinology 2004;145:3055-3061.
32. Abrahám M, Herbison AE: Major sex differences in non-genomic estrogen actions on intracellular signaling in mouse brain in vivo. Neuroscience 2005;131:945-951.
33. Carlstrom L, Ke Z, Unnerstall JR, Cohen RS, Pandey SC: Estrogen modulation of the cyclic AMP response element-binding protein pathway: Effects of long-term and acute treatments. Neuroendocrinology 2001;74;227-243.
34. 2+/calmodulin-dependent protein kinase IV in amygdala. Neuroreport 2001;12:1-4.
35. Zhou J, Pandey SC, Cohen RS: Estrogen decreases the expression of calcineurin in rat amygdala and hippocampus. Neuroreport 2004;15:2437-2440.
36. 2+-and stimulus duration-dependent switch for hippocampal gene expression. Cell 1996;87:1203-1214.
37. Hays J, Ockene J, Brunner RL, Kotchen JM, Manson JE, Patterson R, Aragaki AK, Shumaker SA, Brzyski RG, LaCroix AZ, Granek IA, Valanis BG: Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-1854.
38. De Novaes Soares C, Almeida OP, Joffe H, Cohen LS: Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58:529-534.
39. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca C, Murphy JH, Rubinow DR: Estrogen replacement in perimenopause-related depression: A preliminary report. Am J Obstet Gynecol 2000;183:414-420.
40. Ragson NL, Altshuler LL, Fairbanks LA, Dunkin JJ, Davtyan C, Elman S, Rapkin A: Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. J Clin Psychiatry 2002;63:45-48.
41. Rubinow DR, Schmidt PJ, Roca CA: Estrogen-serotonin interactions: Implications for affective regulation. Biol Psychiatry 1998;44:839-850.
42. Rubinow DR, Schmidt PJ, Roca CA, Daly RC: Gonadal hormones and behavior in women: concentration versus context; in Pfaff DW (ed): Hormones, Brain and Behavior. New York, Academic Press, 2002, vol 5, pp 37-73.
43. Rachman I, Unnerstall JR, Pfaff DW, Cohen RS: Estrogen alters behavior and forebrain c-fos expression in ovariectomized rats subjected to the forced swim test. Proc Natl Acad Sci USA 1998;95:13941-13946.
44. Duman RS, Heninger GR, Nestler EJ: A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54:597-606.
45. Soderling TR: CaM-kinases: Modulators of synaptic plasticity. Curr Opin Neurobiol 2000;10:375-380.
46. O'Connell C, Gallagher HC, O'Malley A, Bourke M, Regan CM: CREB Phosphorylation coincides with transient synapse formation in rat hippocampal dentate gyrus following learning avoidance. Neural Plast 2000;7:279-289.
47. Marie H, Morishita W, Yu X, Calakos N, Malenka RC: Generation of silent synapses by acute in vivo expression of CaMK IV and CREB. Neuron 2005;45:741-752.
48. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay, RM: Antidepressant-like effect of brain-derived neurotrophic factor. Pharmacol Biochem Behav 1997;56: 131-137.
49. Shirayama Y, Chen ACH, Nakagawa S, Russell DS, Duman RS: Brain-derived neurotrophic factor produces antidepressant effects in behavior models of depression. J Neurosci 2002;22:3251-3261.
50. Dias BG, Banerjee SB, Duman RS, Vaidya VA: Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 2003;45:553-563.
51. Monteggia LM, Barrot M, Powell CM, Berton O, Galanis V, Gemelli T, Meuth S, Nagy A, Greene RW, Nestler EJ: Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA 2004;101:10827-10832.
52. Hoshaw BA, Malberg JE, Lucki I: Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res 2005;37:204-208.
53. Hashimoto K, Shimizu E, Iyo M: Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 2004;45:104-114.
54. Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF, Harris CR, Marini AM, Enoch MA, Lipsky RH: BDNF variation and mood disorders: A novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 2005;16:1-9.
55. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR: The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112:257-269.
56. Kow LM, Pfaff DW: Induction of lordosis in female rats: Two models of estrogen action and the effect of adrenalectomy. Horm Behav 1975;6:259-276.
57. Pfaff, DW: Estrogen and Brain Function. Neural Analysis of a Hormone-Controlled Mammalian Reproductive Behavior. New York, Springer, 1980.
58. Rachman IM, Unnerstall JR, Pfaff DW, Cohen RS: Regulation of neuronal nitric oxide synthase mRNA in lordosis-relevant neurons of the ventromedial hypothalamus following short-term estrogen treatment. Brain Res Mol Brain Res 1998;59:105-108.
59. Pandey SC, Roy A, Mittal N: Effects of chronic ethanol intake and its withdrawal on the expression and phosphorylation of the CREB gene transcription factor in rat cortex. J Pharmacol Exp Ther 2001;296:857-868.
60. Pandey SC, Roy A, Zhang H, Xu T: Partial deletion of the cAMP response element-binding protein gene promotes alcohol-drinking behaviors. J Neurosci 2004;24:5022-5030.
61. Pandey SC, Roy A, Zhang H: The decreased phosphorylation of cyclic adenosine monophosphate response element-binding protein in the central amygdala acts as a molecular substrate for anxiety related to ethanol withdrawal in rats. Alcohol Clin Exp Res 2003;27:396-409.
62. A receptor subunit expression in rat neocortical areas. Neuroscience 1997;79:477-487.
63. Izzo E, Auta J, Impagnatiello F, Pesold C, Guidotti A, Costa E: Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines. Proc Natl Acad Sci USA 2001;98:3483-3488.
64. Paxinos SG, Watson, C: The Rat Brain in Sterotaxic Coordinates. New York, Academic Press, 1998.
65. Pandey SC, Mittal N, Lumeng L, Li TK: Involvement of the cyclic AMP-responsive element-binding protein gene transcription factor in genetic preference for alcohol drinking behavior. Alcohol Clin Exp Res 1999;23:1425-1434.
66. Zhang H, Pandey SC: Effects of PKA modulation on the expression of neuropeptide Y in rat amygdaloid structures during ethanol withdrawal. Peptides 2003;24:1397-1402.
67. Bates PJ, Sanderson G, Holgate ST, Johnston SL: A comparison of RT-PCR, in-situ hybridisation and in-situ RT-PCR for the detection of rhinovirus infection in paraffin sections. J Virol Methods 1997;67:153-160.
68. 2+/calmodulin-dependent protein kinase IV. Role in transcriptional regulation. J Biol Chem 1994;269:15520-15527.
69. Kasahara J, Fukunaga K, Miyamoto E: Activation of calcium/calmodulin- dependent protein kinase IV in long-term potentiation in the rat hippocampal CA1 region. J Biol Chem 2001;276:24044-24050.
70. 2+/calmodulin-dependent protein kinase type IV/Gr-deficient mice. J Neurosci 2000;20:6459-6472.
71. 2+/calmodulin kinase IV-deficient mice. J Neurosci 2000;20:RC107.
72. 2+/calmodulin-dependent protein kinase IV. Endocrinology 2000;41:4777-4783.
73. 2+ rise and subsequent cyclic AMP response element-binding protein activation in hippocampal neurons: A potential initiation mechanism for estrogen neurotropism. Neuroscience 2005;132:2299-3111.
74. Tiraboschi E, Tardito D, Kasahara J, Moraschi S, Pruneri P, Gennarelli M, Racagni G, Popoli M: Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology 2004;29:1831-1840.
75. Funabashi T, Brooks PJ, Kleopoulos SP, Grandison L, Mobbs CV, Pfaff DW: Changes in preproenkephalin messenger RNA level in the rat ventromedial hypothalamus during the estrous cycle. Mol Brain Res 1995;28:129-134.
76. Sharrow KM, Kumar A, Foster TC: Calcineurin as a potential contributor in estradiol regulation of hippocampal synaptic function. Neuroscience 2002;113:89-97.
77. Killcross S, Robbins TW, Everitt BJ: Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature 1997;388:377-380.
78. Krȩżel W, Dupont S, Krust A, Chambon P, Chapman PF: Increased anxiety and synaptic plasticity in estrogen receptor-β-deficient mice. Proc Natl Acad Sci USA 2001;98:12278-2282.
79. Womble MD, Andrew JA, Crook JJ: 17β-Estradiol reduces excitatory postsynaptic potential amplitude in rat basolateral amygdale neurons: Neurosci Lett 2002;331:83-86.
80. Morgan MA, Schulkin J, Pfaff DW Estrogens and non-reproductive behaviors related to activity and fear. Neurosci Behav Rev 2004;28:55-63.
81. Davis M, Rannie D. Cassel M: Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci 1994;17:208-214.
82. Shughrue PJ, Lane MV, Merchenthaler I: comparative distribution of estrogen receptor-α and -β RNA in the rat central nervous system. J Comp Neurol 1997;388:507-525.
83. Österlund MK, Kuiper GJM, Gustafsson J, Hurd YL: Differential distribution and regulation of estrogen receptor-α and -β mRNA within the female rat brain. Mol Brain Res 1998;54:175-180.
84. Österlund MK, Hurd YL: Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol 2001;64:251-267.
85. Shima N, Yamaguchi Y, Yuri K: Distribution of estrogen receptor-β mRNA-containing cells in ovariectomized and estrogen-treated female rat brain. Anat Sci Int 2003;78:85-97.
86. Shughrue PJ, Scrimo PJ, Merchenthaler I: Evidence for the colocalization of estrogen receptor-β mRNA and estrogen receptor-α immunoreactivity in neurons of the rat forebrain. Endocrinology 1998 139:5267-5270.
87. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA Jr: Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci 2001;21:7397-403.
88. Newton SS, Thome J, Wallace TL, Shirayama Y, Schlesinger L, Sakai N, Chen J, Neve R, Nestler EJ, Duman RS: Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci 2002;22:10883-10890.
89. Ramos BP, Birnbaum SG, Lindenmayer I, Newton SS, Duman RS, Arnsten AF: Dysregulation of protein kinase a signaling in the aged prefrontal cortex: New strategy for treating age-related cognitive decline. Neuron 2003;40:835-845.
90. Wallace TL, Stellitano KE, Neve RL, Duman RS: Effects of cyclic adenosine monophosphate response element-binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety. Biol Psychiatry 2004;56:151-160.
91. Frye CA, Walf AA: Estrogen and/or progesterone administered systemically or to the amygdala can have anxiety-, fear-, and pain-reducing effects in ovariectomized rats. Behav Neurosci 2004;118:306-313.
92. Berchtold NC, Kesslak JP, Pike CJ, Adlard PA, Cotman CW: Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus. Eur J Neurosci 2001;14:1992-2002.
93. Toran-Allerand CD: The estrogen/neurotrophin connection during neural development: Is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant? Dev Neurosci 1996;18:36-48.
94. Klein-Hitpass L, Ryffel GU, Heitlinger E, Cato AC: A 13-bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucleic Acids Res 1988;6:647-663.
95. Silva AJ, Kogan JH, Frankland PW, Kida S: CREB and memory. Annu Rev Neurosci 1998;21:127-148.
96. Pandey SC: Anxiety and alcohol abuse disorders: A common role for CREB and its target, the neuropeptide Y gene. Trends Pharmacol Sci 2003;24:456-460.
97. Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA: cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 2002;22:3262-3268.
98. Valverde O, Mantamadiotis T, Torrecilla M, Ugedo L, Pineda J, Bleckmann S, Gass P, Kretz O, Mitchell JM, Schütz G, Maldonado R: Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice. Neuropsychopharmacology 2004;29:1122-1133.
99. Nibuya M, Morinobu S, Duman RS: Regulation of BDNF and trkB in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995;15:7539-7547.
100. Porsolt RD, Anton G, Blavet N, Jalfre M: Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol 1978;47: 379-391.
101. Thome T, Sakai N, Shin KH, Steffen C, Zhang YJ, Impey S, Storm D, Duman R: cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 2000;20: 4030-4036.
102. Itoh T, Tokumura M, Abe K: Effects of rolipram, a phosphodiesterase-4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats. Eur J Pharmacol 2004;498:135-142.